Eli Lilly and Company (LILY34) — Free Cash Flow Generation Index
Eli Lilly and Company (LILY34) has a Free Cash Flow Generation Index of 0.08x as of December 2025. Free cash flow of R$254.20 Million represents 0% of operating cash flow (R$3.22 Billion). See Eli Lilly and Company current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Eli Lilly and Company Free Cash Flow Generation Index (2014–2025)
Historical FCF Generation Index trend for Eli Lilly and Company across 12 annual periods. Explore LILY34 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Eli Lilly and Company (2014–2025)
Year-by-year Free Cash Flow Generation Index for Eli Lilly and Company. For the full company profile including market capitalisation, see Eli Lilly and Company market capitalisation.
| Year | FCG Index | Free Cash Flow (BRL) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.35x | R$5.96 Billion | R$16.81 Billion | R$10.85 Billion | ▲ +655.0% |
| 2024 | 0.05x | R$414.30 Million | R$8.82 Billion | R$8.40 Billion | ▲ +262.8% |
| 2023 | -0.03x | R$-164.90 Million | R$5.71 Billion | R$5.88 Billion | ▼ -104.4% |
| 2022 | 0.65x | R$4.60 Billion | R$7.08 Billion | R$1.85 Billion | ▼ -12.5% |
| 2021 | 0.74x | R$5.39 Billion | R$7.26 Billion | R$1.31 Billion | ▲ +7.9% |
| 2020 | 0.69x | R$4.47 Billion | R$6.50 Billion | R$2.03 Billion | ▼ -4.5% |
| 2019 | 0.72x | R$3.48 Billion | R$4.84 Billion | R$1.35 Billion | ▲ +58.7% |
| 2018 | 0.45x | R$2.51 Billion | R$5.52 Billion | R$3.02 Billion | ▼ -26.2% |
| 2017 | 0.61x | R$3.45 Billion | R$5.62 Billion | R$2.16 Billion | ▼ -49.8% |
| 2016 | 1.23x | R$5.94 Billion | R$4.85 Billion | R$1.09 Billion | ▼ -9.9% |
| 2015 | 1.36x | R$4.03 Billion | R$2.96 Billion | R$1.07 Billion | ▲ +7.8% |
| 2014 | 1.26x | R$5.62 Billion | R$4.46 Billion | R$1.16 Billion | — |